Extracellular vesicles as a next-generation drug delivery platform
Top Cited Papers
- 1 July 2021
- journal article
- review article
- Published by Springer Science and Business Media LLC in Nature Nanotechnology
- Vol. 16 (7), 748-759
- https://doi.org/10.1038/s41565-021-00931-2
Abstract
In this Review the authors discuss the biological role of extracellular vesicles and how they can be applied as drug carriers, focusing on the current state of their manufacturing and existing challenges. Extracellular-vesicle-based cell-to-cell communication is conserved across all kingdoms of life. There is compelling evidence that extracellular vesicles are involved in major (patho)physiological processes, including cellular homoeostasis, infection propagation, cancer development and cardiovascular diseases. Various studies suggest that extracellular vesicles have several advantages over conventional synthetic carriers, opening new frontiers for modern drug delivery. Despite extensive research, clinical translation of extracellular-vesicle-based therapies remains challenging. Here, we discuss the uniqueness of extracellular vesicles along with critical design and development steps required to utilize their full potential as drug carriers, including loading methods, in-depth characterization and large-scale manufacturing. We compare the prospects of extracellular vesicles with those of the well established liposomes and provide guidelines to direct the process of developing vesicle-based drug delivery systems.Funding Information
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (181290)
- Bundesministerium für Bildung und Forschung (13XP5029A)
This publication has 110 references indexed in Scilit:
- Molecular Structural AnalysisPublished by Springer Science and Business Media LLC ,2013
- Manufacture of the Biologic APIPublished by Springer Science and Business Media LLC ,2013
- Source Materials for BiologicsPublished by Springer Science and Business Media LLC ,2013
- The mesenchymal stromal cells dilemma—does a negative phase III trial of random donor mesenchymal stromal cells in steroid-resistant graft-versus-host disease represent a death knell or a bump in the road?Cytotherapy, 2013
- Active Wnt proteins are secreted on exosomesNature, 2012
- Unidirectional transfer of microRNA-loaded exosomes from T cells to antigen-presenting cellsNature Communications, 2011
- SiRNA delivery with exosome nanoparticlesNature Biotechnology, 2011
- Delivery of siRNA to the mouse brain by systemic injection of targeted exosomesNature Biotechnology, 2011
- A Novel Nanoparticle Drug Delivery System: The Anti-inflammatory Activity of Curcumin Is Enhanced When Encapsulated in ExosomesMolecular Therapy, 2010
- Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cellsNature, 2007